Perspective Therapeutics ... (CATX)
AMEX: CATX
· Real-Time Price · USD
3.17
-0.05 (-1.55%)
At close: Jun 13, 2025, 3:59 PM
3.16
-0.32%
After-hours: Jun 13, 2025, 05:31 PM EDT
-1.55% (1D)
| Bid | 2.98 |
| Market Cap | 235.3M |
| Revenue (ttm) | n/a |
| Net Income (ttm) | -79.28M |
| EPS (ttm) | -1.23 |
| PE Ratio (ttm) | -2.58 |
| Forward PE | -2.5 |
| Analyst | Buy |
| Ask | 3.34 |
| Volume | 752,662 |
| Avg. Volume (20D) | 989,971 |
| Open | 3.16 |
| Previous Close | 3.22 |
| Day's Range | 3.04 - 3.29 |
| 52-Week Range | 1.60 - 16.55 |
| Beta | 1.12 |
About CATX
undefined
Industry n/a
Sector n/a
IPO Date n/a
Employees NaN
Stock Exchange n/a
Ticker Symbol CATX
Website n/a
Analyst Forecast
According to 0 analyst ratings, the average rating for CATX stock is "n/a." The 12-month stock price forecast is $n/a, which is a decrease of 0% from the latest price.
Stock Forecasts1 week ago
+29.29%
Perspective Therapeutics shares are trading higher...
Unlock content with
Pro Subscription
6 months ago
-51.38%
Perspective Therapeutics shares are trading lower. The company announced initial results from its ongoing Phase 1/2a clinical trial of [212Pb]VMT-α-NET.
